Solventum Corporation SOLV

Full chart Compare
Set alert

Price alert · SOLV

All alert types
88.88 USD -0.47 (-0.52%)

Nov 5, 2026, 10:48 AM EST

88.00 Day range 90.26
62.49 52-week range 92.44
YTD
+12.17%
1 year
+31.31%
Market cap
15.12B
Revenue (ttm)
8.31B
Profit margin
17.26%
EPS (ttm)
8.17
Shares out
170.22M
P/E ratio
10.87
Forward P/E
12.29
YTD return
+12.17%
1-year return
+31.31%
Volume
185.28K
Avg volume
1.04M
Open
90.34
Previous close
89.35
Day's range
88.00 – 90.26
52-week range
62.49 – 92.44
Beta
0.75
Analysts
Buy
Price target
94.69 (+6.5%)
Earnings date
Nov 5, 2026

2Y +15.70 (+21.46%)

708090Jan 25Jun 25Nov 25Apr 26Aug 2688.86

Key statistics

Enterprise value
19.32B
PEG ratio
1.22
Price / sales
1.83
Price / book
3.17
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
2.20%
Free cash flow
489.00M
Total cash
403.00M
Total debt
5.30B
Return on equity
33.96%
Short % of float
3.43%
50-day average
87.87
200-day average
78.42

Financials — quick view

All financials
SOLV Revenue — quarterly 2.21B
2023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SOLV Net income — quarterly 92.00M
2023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SOLV EPS — quarterly 0.53
2023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

SOLV recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 20261.34———
Aug 5, 2026Jun 30, 20261.902.55+0.65+34.21%
May 5, 2026Mar 31, 20261.351.48+0.13+9.63%
Feb 26, 2026Dec 31, 20251.501.57+0.07+4.67%
Nov 6, 2025Sep 30, 20251.431.50+0.07+4.90%
Aug 7, 2025Jun 30, 20251.451.69+0.24+16.55%

Upgrades / downgrades

SOLV analyst upgrades and downgrades
DateFirmActionFromTo
Sep 14, 2026BTIGreitBuyBuy
Aug 6, 2026UBSmainBuyBuy
Aug 6, 2026Piper SandlermainOverweightOverweight
Aug 6, 2026WedbushmainOutperformOutperform
Aug 6, 2026KeybancmainOverweightOverweight
Aug 6, 2026StifelmainBuyBuy

About Solventum Corporation

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on SOLV — it syncs with the Stock Master app.

Insider holders

SOLV insider holders
InsiderRelationLatest transactionDateShares held
3M COBeneficial Owner of more than 10% of a Class of SecuritySaleAug 14, 202525,569,200
COX CARRIE SMITHDirectorConversion of Exercise of derivative securityApr 29, 202616,400
GOMEZ TAMMY LOfficerConversion of Exercise of derivative securityMay 12, 202613,362
HANSON BRYAN CRAIGChief Executive OfficerConversion of Exercise of derivative securityAug 31, 2026185,515
HARRINGTON PAUL SOfficerConversion of Exercise of derivative securityMay 12, 202620,452
KIRBERGER MARCELA A.OfficerConversion of Exercise of derivative securityMay 12, 202613,540

Institution ownership

SOLV institution ownership
Holder% heldSharesValueReported
Independent Franchise Partners, LLP9.50%16,170,0381.44BJun 29, 2026
Blackrock Inc.5.73%9,761,863871.83MJun 29, 2026
Vanguard Capital Management LLC5.65%9,624,829859.59MJun 29, 2026
Trian Fund Management, LP4.84%8,236,753735.62MJun 29, 2026
Vanguard Portfolio Management LLC3.72%6,328,641565.21MJun 29, 2026
Davis Selected Advisers3.71%6,307,729563.34MJun 29, 2026

Fund ownership

SOLV fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.75%4,674,934417.52MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.24%3,816,022340.81MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.98%3,375,087301.43MJun 29, 2026
John Hancock Funds III-Disciplined Value Mid Cap Fund1.40%2,385,590213.06MAug 30, 2026
Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF1.28%2,172,808194.05MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund1.26%2,138,463190.99MJun 29, 2026